CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaotao,Qian ^[1] ; Xuekun,Song ^[2] ; Yuan,He ^[1] ; Zhiyong,Yang ^[3] ; Tao,Sun ^[4] ; Jing,Wang ^[5] ; Guiqi,Zhu ^[6] ; Weihai,Xing ^[7] ; Changxuan,You ^[8]

作者单位： Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. ^[1] School of Information Technology, Henan University of Traditional Chinese Medicine, Zhengzhou450008, China. ^[2] Department of Radiontherapy, Huanggang Central Hospital, Huanggang 438000, China. ^[3] Department of Thoracic Surgery, Fuyang Second People's Hospital, Fuyang 236015, China. ^[4] Department of Oncology, Fuyang Tumor Hospital, Fuyang 236018, China. ^[5] Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China. ^[6] Department of Pathology, Fifth People's Hospital of Fuyang, Fuyang 23600, China. ^[7] Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address: ycx_6026@163.com. ^[8]

关键词 Biomarker CCNB2 NSCLC Prognosis

主题词成年人(Adult);老年人(Aged);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);细胞周期蛋白B2(Cyclin B2);疾病恶化(Disease Progression);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);肺肿瘤(Lung Neoplasms);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);预后(Prognosis);RNA, 信使(RNA, Messenger);存活率(Survival Rate);青年人(Young Adult)

DOI 10.1016/j.biopha.2015.08.004

PMID 26349989

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览76

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

2015年74卷

222-7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相似文献

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相似文献

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

相关期刊

检索历史清除